Impact of Chronic Obstructive Pulmonary Disease on Valve Academic Research Consortium Defined Outcomes After Transcatheter Aortic Valve Implantation. (from the FRANCE 2 Registry)

Affiliation auteurs!!!! Error affiliation !!!!
TitreImpact of Chronic Obstructive Pulmonary Disease on Valve Academic Research Consortium Defined Outcomes After Transcatheter Aortic Valve Implantation. (from the FRANCE 2 Registry)
Type de publicationJournal Article
Year of Publication2014
AuteursChopard R, Meneveau N, Chocron S, Gilard M, Laskar M, Eltchaninoff H, Iung B, Leprince P, Teiger E, Chevreul K, Prat A, Lievre M, Leguerrier A, Donzeau-Gouge P, Fajadet J, Schiele F
JournalAMERICAN JOURNAL OF CARDIOLOGY
Volume113
Pagination1543–1549
Date PublishedMAY 1
Type of ArticleArticle
ISSN0002-9149
Résumé

{The purposes of the present study were to determine the impact of chronic obstructive pulmonary disease (COPD) on Valve Academic Research Consortium defined outcomes in patients undergoing trans,catheter aortic valve implantation (TAVI). A total of 3,933 consecutive patients underwent TAVI from January 2010 to December 2011 in 34 centers and were included in the French national TAVI registry ``FRANCE 2''; 895 (22.7%) had concomitant COPD, 3,038 (77.3%) did not. There were no significant differences in procedural characteristics or 30-day Valve Academic Research Consortium defined outcomes between those with and without COPD. Multivariate regression analysis showed COPD to be an independent predictor of 1-year mortality and combined efficacy end point after adjustment for concomitant co-morbidities (hazard ratio 1.19, 95% confidence interval 1.005 to 1.41
DOI10.1016/j.amjcard.2014.01.432